Peptris Technologies

📍 Bengaluru, India🗓 Founded 2019👥 11 employees💰 Last funded Jan 2026
Biotechnology Research🌐 peptris.com
Website LinkedIn
Peptris is an AI powered preclinical drug discovery company working on oncology, inflammation and rare diseases. At Peptris, we have created an array of AI models to predict various parameters that are critical for a novel molecule to be considered a potential drug candidate. All these models are orchestrated by an automated pipeline that prunes large purchasable compound datasets to identify potential hits and also creates denovo variations of compounds that are predicted to be novel, potent, safe, selective, and active clinically. The pipeline ensures that the number of compounds to be tested and validated in a wet lab are minimal, making our discovery efficient, faster and cost effective. We have some exciting wet lab results from our proprietary discovery programs and we are currently accelerating them into preclinical development.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
India
3
Investor activity2023–2026 · investors recorded per year
202312025120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Peptris Technologies?
Peptris Technologies has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did Peptris Technologies last raise funding?
The most recent investment in Peptris Technologies recorded on gritt.io was in January 2026.
When was Peptris Technologies founded?
Peptris Technologies was founded in 2019.
What industry is Peptris Technologies in?
Peptris Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Peptris Technologies based?
Peptris Technologies is headquartered in Bengaluru, India.